High-Dose Influenza Vaccine in Nursing Homes

PHASE4UnknownINTERVENTIONAL
Enrollment

823

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 15, 2017

Study Completion Date

September 30, 2018

Conditions
Influenza
Interventions
BIOLOGICAL

HD Vaccine

Nursing home residents over 65 years are allocated to receive high-dose vaccine. Residents under 65 years are provided standard-dose vaccine.

BIOLOGICAL

SD Vaccine

Nursing home residents are allocated to receive standard-dose vaccine.

BIOLOGICAL

Free Vaccine

Nursing home facilities are provided free standard-dose vaccine for their staff.

BIOLOGICAL

Usual Care

Nursing home staff will have access to influenza vaccine, per standard of care. No free vaccine provided as part of study.

Trial Locations (3)

23510

Insight Therapeutics, LLC, Norfolk

44106

Case Western Reserve University, Cleveland

02912

Brown University, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brown University

OTHER

collaborator

Case Western Reserve University

OTHER

lead

Insight Therapeutics, LLC

OTHER